Skip to main content
. 2018 May 26;16(6):184. doi: 10.3390/md16060184

Figure 3.

Figure 3

Effect of MAG-DHA on expression levels of circulating IL-6 in CF patients. (A) IL-6 levels were assessed using specific ELISA in plasma of healthy subjects (n = 6) and CF patients of placebo group before (n = 5) and after 30 (n = 5) and 60 days (n = 2) of supplementation. (B) IL-6 levels in plasma of healthy subjects (n = 6) and CF patients of MAG-DHA group before (n = 6) and after 30 (n = 6) and 60 days (n = 3) of daily supplementation. (C) Bar graph displaying changes in IL-6 levels after 30 days of placebo (n = 5) or MAG-DHA (n = 6) daily intake in CF patients. (D) Bar graph displaying changes in IL-6 levels after 60 days of placebo (n = 2) or MAG-DHA (n = 3) supplementation CF patients. Results are expressed as means ± SEM, * p ≤ 0.05.